Company Information
CIN
Status
Date of Incorporation
24 September 2003
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
29 September 2023
Paid Up Capital
81,778,820
Authorised Capital
150,000,000
Directors
Swapnil Singh
Director/Designated Partner
over 2 years ago
over 2 years ago
Kristian Philip Ruepp
Director/Designated Partner
about 6 years ago
about 6 years ago
Dieter Schoenfeld
Director/Designated Partner
almost 22 years ago
almost 22 years ago
Past Directors
Kiran Kumar Madallapalli
Director
about 5 years ago
about 5 years ago
Oliver Robert Alexander Schrader
Additional Director
almost 7 years ago
almost 7 years ago
Dr Georg Stark
Additional Director
over 10 years ago
over 10 years ago
Balaramesha Chary Rallabandi
Managing Director
over 14 years ago
over 14 years ago
Srinivasa Rao Battula
Managing Director
over 14 years ago
over 14 years ago
Hans Martin Konrad Schwarm
Director
about 15 years ago
about 15 years ago
Registered Trademarks
[Class : 5] Pharmaceutical Drug For Medicinal Purposes
[Class : 5] Pharmaceutical Drug For Medicinal Purposes
[Class : 5] Pharmaceutical Drug For Medicinal Purposes
View +3 more Brands for Aet Laboratories Private Limited.
Charges
26 April 2021
Hdfc Bank Limited
7 Lak
16 April 2021
Hdfc Bank Limited
7 Lak
11 November 2022
The Hongkong And Shanghai Banking Corporation Limited
0
26 April 2021
Hdfc Bank Limited
0
16 April 2021
Hdfc Bank Limited
0
11 November 2022
The Hongkong And Shanghai Banking Corporation Limited
0
26 April 2021
Hdfc Bank Limited
0
16 April 2021
Hdfc Bank Limited
0
11 November 2022
The Hongkong And Shanghai Banking Corporation Limited
0
26 April 2021
Hdfc Bank Limited
0
16 April 2021
Hdfc Bank Limited
0
Documents
Form DPT-3-20012021-signed
Form MGT-7-03122020_signed
Optional Attachment-(1)-02122020
Copy of MGT-8-02122020
List of share holders, debenture holders;-02122020
Form BEN - 2-01122020_signed
Declaration under section 90-27112020
Form MGT-14-24112020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-24112020
Form DIR-12-07112020_signed
Declaration by first director-06112020
Form DIR-12-04112020_signed
Evidence of cessation;-03112020
Optional Attachment-(1)-03112020
Optional Attachment-(2)-03112020
Optional Attachment-(3)-03112020
Notice of resignation;-03112020
Form DIR-12-01112020_signed
Form AOC-4(XBRL)-30102020_signed
XBRL document in respect Consolidated financial statement-29102020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-29102020
Optional Attachment-(1)-29102020
Optional Attachment-(1)-17092020
Form DIR-12-15092020_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-14092020
Optional Attachment-(1)-14092020
Optional Attachment-(3)-14092020
Optional Attachment-(2)-14092020
Optional Attachment-(4)-14092020
Form DIR-12-30062020_signed
